BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15632178)

  • 1. Mitotic phosphorylation rescues Abl from F-actin-mediated inhibition.
    Woodring PJ; Hunter T; Wang JY
    J Biol Chem; 2005 Mar; 280(11):10318-25. PubMed ID: 15632178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of c-Abl tyrosine kinase activity by filamentous actin.
    Woodring PJ; Hunter T; Wang JY
    J Biol Chem; 2001 Jul; 276(29):27104-10. PubMed ID: 11309382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Abl tyrosine kinase binds and phosphorylates phospholipid scramblase 1.
    Sun J; Zhao J; Schwartz MA; Wang JY; Wiedmer T; Sims PJ
    J Biol Chem; 2001 Aug; 276(31):28984-90. PubMed ID: 11390389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crk family adaptor proteins trans-activate c-Abl kinase.
    Shishido T; Akagi T; Chalmers A; Maeda M; Terada T; Georgescu MM; Hanafusa H
    Genes Cells; 2001 May; 6(5):431-40. PubMed ID: 11380621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
    Van Etten RA; Debnath J; Zhou H; Casasnovas JM
    Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
    Mayer BJ; Baltimore D
    Mol Cell Biol; 1994 May; 14(5):2883-94. PubMed ID: 8164650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
    Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dok-R binds c-Abl and regulates Abl kinase activity and mediates cytoskeletal reorganization.
    Master Z; Tran J; Bishnoi A; Chen SH; Ebos JM; Van Slyke P; Kerbel RS; Dumont DJ
    J Biol Chem; 2003 Aug; 278(32):30170-9. PubMed ID: 12777393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential SH3 domain-binding site in the Crk SH2 domain.
    Anafi M; Rosen MK; Gish GD; Kay LE; Pawson T
    J Biol Chem; 1996 Aug; 271(35):21365-74. PubMed ID: 8702917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the N-methyl-D-aspartic acid receptor NR2D subunit with the c-Abl tyrosine kinase.
    Glover RT; Angiolieri M; Kelly S; Monaghan DT; Wang JY; Smithgall TE; Buller AL
    J Biol Chem; 2000 Apr; 275(17):12725-9. PubMed ID: 10777567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases.
    Mayer BJ; Hirai H; Sakai R
    Curr Biol; 1995 Mar; 5(3):296-305. PubMed ID: 7780740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
    Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ
    Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core.
    Chen S; O'Reilly LP; Smithgall TE; Engen JR
    J Mol Biol; 2008 Nov; 383(2):414-23. PubMed ID: 18775435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity.
    Van Etten RA; Jackson PK; Baltimore D; Sanders MC; Matsudaira PT; Janmey PA
    J Cell Biol; 1994 Feb; 124(3):325-40. PubMed ID: 8294516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a binding site in c-Ab1 tyrosine kinase for the C-terminal repeated domain of RNA polymerase II.
    Baskaran R; Chiang GG; Wang JY
    Mol Cell Biol; 1996 Jul; 16(7):3361-9. PubMed ID: 8668151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intramolecular SH3-domain interaction regulates c-Abl activity.
    Barilá D; Superti-Furga G
    Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src homology 2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain.
    Duyster J; Baskaran R; Wang JY
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1555-9. PubMed ID: 7533294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions.
    Weng Z; Rickles RJ; Feng S; Richard S; Shaw AS; Schreiber SL; Brugge JS
    Mol Cell Biol; 1995 Oct; 15(10):5627-34. PubMed ID: 7565714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.